The Valley Desk

NCT02133924 · Interventional trial

Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

Overall registry status Completed

Phase 2

Conditions Acute Graft Versus Host Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov